Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction

A Multicenter Prospective Observational Study to Evaluate the Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction (AMI)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02641184

Enrollment

3000

Registered

2015-12-29

Start date

2015-12-31

Completion date

Unknown

Last updated

2016-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention

Keywords

Myocardial Infarction, Cardiovascular Diseases, Heart Diseases, Infarction, Diabetes

Brief summary

The aim of this study is to investigate the potential novel risk factors for acute myocardial infarction. Predictors of poor outcomes will be also evaluated.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Less than 12 hours after the onset of myocardial infarction symptoms * Myocardial necrosis, as evidenced by increased Creatine Kinase Isoenzyme (CK-MB) or troponin levels

Exclusion criteria

* Age under 18 years-old

Design outcomes

Primary

Measure	Time frame	Description
Major adverse cardiovascular events (MACE)	maximum 5 years	Composite of angina pectoris, reinfarction, unplanned rehospitalization, stent thrombosis, incidence of cardiac death in the duration of follow-up

Secondary

Measure	Time frame	Description
Length of hospital stay	in the phase of hospital stay, maximum 30 days	The length of in-hospital stay is counted as a secondary outcome
New-onset diabetes	the duration of follow-up, maximum 5 years	New-onset diabetes are defined as newly-diagnosed type 2 diabetes mellitus

Countries

China

Outcome results